tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ENGN Stock Latest News

enGene Holdings Amends CEO Severance Package
Company AnnouncementsenGene Holdings Amends CEO Severance Package
8d ago
8K
ENGN
enGene Holdings Grants Inducement Equity Awards to New Hires
PremiumCompany Announcements
enGene Holdings Grants Inducement Equity Awards to New Hires
9d ago
ENGN
enGene Holdings Appoints New Chief Medical Officer
PremiumCompany Announcements
enGene Holdings Appoints New Chief Medical Officer
10d ago
8K
ENGN
enGene appoints Sweiti as Chief Medical Officer
PremiumThe Fly
enGene appoints Sweiti as Chief Medical Officer
10d ago
JNJ
ENGN
Citizens JMP healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
24d ago
JNJ
CGON
enGene price target lowered to $18 from $19 at Morgan Stanley
PremiumThe FlyenGene price target lowered to $18 from $19 at Morgan Stanley
28d ago
ENGN
Buy Rating for enGene Holdings: Strategic Positioning and Competitive Edge in NMIBC Market
Premium
Ratings
Buy Rating for enGene Holdings: Strategic Positioning and Competitive Edge in NMIBC Market
28d ago
ENGN
enGene Holdings Reports Q3 2025 Results and Milestones
Premium
Company Announcements
enGene Holdings Reports Q3 2025 Results and Milestones
29d ago
ENGN
enGene Holdings Achieves Key Milestone in LEGEND Trial and Secures RMAT Designation
PremiumCompany Announcements
enGene Holdings Achieves Key Milestone in LEGEND Trial and Secures RMAT Designation
29d ago
ENGN
enGene reports Q3 EPS 57c vs. 32c last year
PremiumThe Fly
enGene reports Q3 EPS 57c vs. 32c last year
29d ago
ENGN
Citizens JMP healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
1M ago
JNJ
CGON
enGene Reaches Key Enrollment Milestone in LEGEND Trial for Bladder Cancer Therapy
PremiumCompany Announcements
enGene Reaches Key Enrollment Milestone in LEGEND Trial for Bladder Cancer Therapy
1M ago
ENGN
enGene achieves target enrollment in LEGEND trial of detalimogene voraplasmid
PremiumThe FlyenGene achieves target enrollment in LEGEND trial of detalimogene voraplasmid
1M ago
ENGN
enGene Holdings to Engage in September Investor Conferences
Premium
Company Announcements
enGene Holdings to Engage in September Investor Conferences
1M ago
ENGN
enGene Holdings Grants Inducement Equity Awards to New Employees
Premium
Company Announcements
enGene Holdings Grants Inducement Equity Awards to New Employees
2M ago
ENGN
enGene Holdings Expands Board with New Appointments
PremiumCompany Announcements
enGene Holdings Expands Board with New Appointments
3M ago
8K
ENGN
enGene names Matthew Boyd CRO, Jill Buck CDO
PremiumThe Fly
enGene names Matthew Boyd CRO, Jill Buck CDO
3M ago
ENGN
enGene gets Regenerative Medicine Advanced Therapy designation for detalimogene
PremiumThe Fly
enGene gets Regenerative Medicine Advanced Therapy designation for detalimogene
4M ago
ENGN
Optimistic Buy Rating for enGene Holdings Amid LEGEND Study Progress and Regulatory Advancements
PremiumRatings
Optimistic Buy Rating for enGene Holdings Amid LEGEND Study Progress and Regulatory Advancements
4M ago
ENGN
enGene price target lowered to $19 from $34 at Morgan Stanley
PremiumThe FlyenGene price target lowered to $19 from $34 at Morgan Stanley
4M ago
ENGN
enGene Holdings Reports Q2 2025 Financial Results
Premium
Company Announcements
enGene Holdings Reports Q2 2025 Financial Results
4M ago
ENGN
enGene Holdings Approves 2025 Employee Stock Purchase Plan
Premium
Company Announcements
enGene Holdings Approves 2025 Employee Stock Purchase Plan
4M ago
8K
ENGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >